1632 results
Unfavorable access in TAVI
21 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 session will enable you to appreciate an aortic valve-in-valve intervention through right subclavian access, observe a transfemoral TAVI through extremely tortuous aorta, view a challenging case of left axillary access TAVI in bicuspid aortic stenosis, and much more!
...Not just TAVI
21 Nov 2021 – From PCR London Valves 2021
Browse this page to discover simultaneous TAVR and tricuspid valve-in-valve, combined percutaneous valve-in-valve TAVI and mitral repair in degenerated freestyle full root, paravalvular leak post TAVR causing hemolysis treated with balloon dilatation and PVL closure, and much more!
Challenging routes for TAVI
21 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to look at transfemoral TAVR in patient with severe stenosis of iliac artery, to appreciate a transfemoral aortic valve replacement in a patient affected by abdomen aorta barrage, and more!
Coronaries and TAVI
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos and learn about TAVR in rheumatic patient with aortic regurgitation, IVUS assessment of coronary ostia following transapical ViV TAVI, "Hybrid thinking" off-pump CABG and TAVI for left main disease and CTO with severe aortic stenosis, and more!
Unusual situations during TAVI
21 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to benefit from the experience of our speakers and discover, among others, ECMO assistance during TAVI in high-risk patient with recent COVID-19 pneumonia, bailout "balloon trapping technic" to facilitate crossing the aortic valve during TAVI, or how to manage residual...
TAVI complications
21 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 to appreciate the hybrid management of double aortic root rupture complicating TAVI, learn about an unexpected cause for complication during TAVR, investigate acute left main occlusion during TAVI, and much more!
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis
07 Nov 2021
Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.
Author
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure
06 Nov 2021
TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.
Author
PCRonline @ TCT 2021 - Get the international perspective!
03 Nov 2021
Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
19 Oct 2021
In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.
Reviewer
Reviewer
PCR TV: Valve selection considerations for the Heart Team
11 Oct 2021
Which valve for which patient? The question is no longer just whether to choose a balloon-expandable or a self-expanding valve: low-risk indications, increasing number of TAVI procedures, and growing complexity of patients are leading the TAVI community to become more prescriptive and to take time to...
TAVI in Asia-Pacific 2021: an update
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to be updated on the state of TAVI in 2021, especially in the Asia-Pacific Region, and learn more about the essential steps of TAVI procedure in a bicuspid valve.
Best cases and research unveiled at AICT-Asia PCR 2021
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to discover some of the best cases and research unveiled at AICT-Asia PCR 2021: positive remodelling of coronary arteries on CT coronary angiogram, investigation of heavy metals in coronary artery tissues in autopsy cases, DEB vs. DES in the main vessel for treatment of...
Complications: calcified LM-LAD PCI, CHIP and TAVI
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session on complications to see 3 clinical cases: "calcified LM-LAD PCI with rotablator", "cascading events in a CHIP case" and "complications in TAVI", and discover how they managed to face them.
Cases on valvular disease
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover various interesting cases on valvular disease, such as the implantation of a transcatheter aortic VIV for an acute AR in prior bio Bentall operation, the percutaneous pulmonic balloon valvuloplasty in a carcinoid pulmonic stenosis, as well as the percutaneous valve-in-valve in the...
Abstracts on TAVI
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of abstracts on TAVI, and learn more about the operator preference and determinants of size when additional intermediate-size aortic THVs available, the comparative quantitative aortographic assessment of regurgitation in six self-expanding valves, as well as the chronic hemodynamic performance...
TAVI procedure optimisation with the cusp overlap technique
27 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...
Addressing the challenges of small annuli patients with the Evolut Platform
27 Sep 2021 – From PCR Tokyo Valves 2021
Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...
Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology
27 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...
